The U.S. Food and Drug Administration on Tuesday amended the terms of its emergency use authorizations for the bivalent vaccines from Pfizer and Moderna, allowing people 65 and older and certain people with weakened immunity to receive additional doses ahead of vaccination campaigns this fall. The bivalent vaccines manufactured by Pfizer and Moderna carry instructions